auto_awesome_motion View all 2 versions
organization

AESCULAP AG

Country: Germany
3 Projects, page 1 of 1
  • Open Access mandate for Publications and Research data
    Funder: EC Project Code: 766012
    Overall Budget: 1,588,450 EURFunder Contribution: 1,588,450 EUR
    Partners: UNIBO, ADAGOS, FINCERAMIC, BUDAI EGESZSEGKOZPONT KFT, University of Sheffield, Ansys (France), AESCULAP AG

    The SPINNER EID will train a group of Bioengineering early stage researchers to be in a position to design the next generation of repair materials and techniques for spine surgery. SPINNER brings together partners from the biomaterials (Finceramica), implantable devices (Aesculap), and computational modelling (Ansys, Adagos) industries with orthopaedic clinicians (National Centre for Spinal Disorders, NCSD) and academic experts in cell, tissue and organ scale biomaterials and medical device testing (Universities of Sheffield and Bologna). All projects will be fully grounded in practical industrial and clinical requirements, where the number of patients requiring complex spine surgery is rapidly expanding, and the biomedical engineering industry needs suitably trained, innovators to produce economic solutions to support healthy ageing for the people of Europe.

  • Funder: EC Project Code: 310477
    Partners: Uppsala University, PETER BREHM, LiU, Simulation Solutions (United Kingdom), ETH Zurich, Imperial, TUHH, UZH, AnyBody Technology A/S, SCHULTHESS KLINIK...
  • Open Access mandate for Publications
    Funder: EC Project Code: 876190
    Overall Budget: 65,555,000 EURFunder Contribution: 16,863,700 EUR
    Partners: INESC ID, MICRONIT, University of Freiburg, UPV/EHU, CORTEC, IHS WEIGLING SOCIEDAD LIMITADA, REMOTEA OY, IMEC, FUNDACION INSTITUTO DE INVESTIGACION SANITARIA ARAGON, MCS...

    Compared to the pace of innovation in electronic consumer products, the pace of innovation for medical devices is lagging behind. It is the overarching objective of Moore4Medical to accelerate innovation in electronic medical devices. Moore4Medical emerging medical applications that offer significant new opportunities for the ECS industry including: active implantable devices (bioelectronic medicines), organ-on-chip, drug adherence monitoring, smart ultrasound, radiation free interventions and continuous monitoring. The new technologies will help fighting the increasing cost of healthcare by: reducing the need for hospitalization, helping the development of personalized therapies, and realizing intelligent point-of-care diagnostic tools. Moore4Medical will bring together 68 specialists from 12 countries who will develop open technology platforms for these emerging fields to help them bridge “the Valley of Death” in shorter time and at lower cost. Open technology platforms used by multiple users for multiple applications with the prospect of medium to high volume markets are an attractive proposition for the European ECS industry. The combination of typical MedTech applications with an ECS style platform approach will enhance the competitiveness for the emerging medical domains addressed in Moore4Medical. With value and IP moving from the technology level towards applications and solutions, defragmentation and open technology platforms will be key in acquiring and maintaining a premier position for Europe in the forefront of affordable healthcare